Delivery Order SPE2DE21D0005-SPE2D625F0AY0
Award Date 5/30/25
Potential Completion Date 6/4/25
Potential Value $2.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Canton, MA 02021, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
65
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Organogenesis Inc., a regenerative medicine company headquartered in Canton, Massachusetts, was awarded a delivery order valued at $1,239.95 for APLIGRAF, an advanced wound care and tissue regeneration product. The contract, awarded on May 30, 2025, with an ultimate completion date of June 4, 2025, utilizes fixed-price pricing with economic price adjustment terms. The award was made without a set-aside designation, indicating that Organogenesis competed as a standard commercial vendor. The...
- Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts, was awarded a delivery order valued at $2,479.90 by the Defense Logistics Agency's Medical Supply Chain division on September 23, 2025. The contract, which operates under a fixed-price arrangement with economic price adjustment provisions, is for the supply of APLIGRAF, an advanced wound care and tissue regeneration product. The delivery order is scheduled for completion by September 26, 2025, and was awarded...
- On May 12, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,239.95 to Organogenesis Inc. for APLIGRAF, an advanced regenerative medicine product used in wound care and tissue regeneration. The contract is classified as fixed price with economic price adjustment and carries an ultimate completion date of May 15, 2025. This delivery order was issued without set-aside designation, reflecting Organogenesis's status as a standard commercial vendor...
- Organogenesis Inc., a Canton, Massachusetts-based regenerative medicine company, received a delivery order award valued at $1,239.95 from the Defense Logistics Agency's Medical Supply Chain for APLIGRAF, an advanced wound care and tissue regeneration product. The contract, awarded on May 7, 2025, carries a fixed price structure with economic price adjustment provisions and is scheduled for completion by May 12, 2025. No set-aside designation was used in this award, indicating Organogenesis...
- This federal contract award is for the delivery of APLIGRAF, a skin substitute product, to the Department of Defense (DoD) and the Department of Veterans Affairs (VA). The contract, awarded to Organogenesis Inc., a regenerative medicine company, has a ceiling value of $1,239.95 and a completion date of May 23, 2025. It is a Delivery Order contract with a Fixed Price with Economic Price Adjustment pricing type. The contract is not a set-aside. Organogenesis is a key supplier of advanced wound...
- Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts, was awarded a delivery order valued at $5,790.00 by the Defense Logistics Agency's Medical Supply Chain on August 11, 2025, with an ultimate completion date of August 14, 2025. The contract is for PURAPLY AM XT 4.91X4.91, an advanced wound care dressing used for surgical and wound treatment applications. The award utilized fixed-price pricing with economic price adjustment provisions and was not designated as a...
- This federal contract award to Organogenesis Inc., a leading regenerative medicine company, is for the delivery of APLIGRAF, a tissue regeneration product. The $1,239.95 fixed-price with economic price adjustment contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and has a completion date of September 25, 2024. Organogenesis holds several significant Indefinite Delivery Vehicles (IDVs) with federal agencies, including a $25 million single-award...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company specializing in advanced wound care, surgical biologics, and tissue regeneration products. The contract is for the supply of the company's APLIGRAF product, a specialized skin substitute used in medical treatments. The $1,239.95 fixed-price contract with economic price adjustment has a completion date of November 13, 2024....
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $2,479.90 Delivery Order contract to Organogenesis Inc., a leading regenerative medicine company, to provide APLIGRAF, a specialized skin substitute and wound matrix product. The contract has a period of performance through November 25, 2024 and utilizes a Fixed Price with Economic Price Adjustment pricing structure. Organogenesis is a for-profit manufacturer that has been awarded numerous federal contracts to supply a range...
- This is a $1,239.95 fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Organogenesis Inc., a regenerative medicine company. The order is for the company's APLIGRAF product, which is a wound dressing and tissue regeneration solution. Organogenesis has been awarded numerous prime federal contracts by the DLA and Department of Veterans Affairs (VA) to provide advanced wound care and surgical products. This specific award is not associated with a set-aside program....